PMID-sentid Pub_year Sent_text compound_name comp_offset prot_official_name organism prot_offset 17764562-1 2007 INTRODUCTION: 1,1-Bis (3"-indolyl)-1-(p-biphenyl) methane (CDIM9) has been identified as a new peroxisome proliferator-activated receptor (PPAR)-gamma agonist that exhibits both receptor dependent and independent antitumor activities. cdim9 59-64 peroxisome proliferator activated receptor gamma Mus musculus 95-150 17764562-7 2007 In MDA-MB231 cell, CDIM9 induced caveolin-1 and p27 expression, which was significantly downregulated by co-treatment with the PPAR-gamma antagonist GW9662. cdim9 19-24 caveolin 1 Homo sapiens 33-43 17764562-7 2007 In MDA-MB231 cell, CDIM9 induced caveolin-1 and p27 expression, which was significantly downregulated by co-treatment with the PPAR-gamma antagonist GW9662. cdim9 19-24 interferon alpha inducible protein 27 Homo sapiens 48-51 17764562-7 2007 In MDA-MB231 cell, CDIM9 induced caveolin-1 and p27 expression, which was significantly downregulated by co-treatment with the PPAR-gamma antagonist GW9662. cdim9 19-24 peroxisome proliferator activated receptor gamma Homo sapiens 127-137 17764562-12 2007 CDIM9 induced increases in tumor caveolin-1 and p27 in vivo, which may contribute to its antitumor activity in basal-like breast cancer. cdim9 0-5 caveolin 1, caveolae protein Mus musculus 33-43 17764562-12 2007 CDIM9 induced increases in tumor caveolin-1 and p27 in vivo, which may contribute to its antitumor activity in basal-like breast cancer. cdim9 0-5 cyclin-dependent kinase inhibitor 1B Mus musculus 48-51